. The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols. Theor Med Bioeth. 2020 Dec;41(5-6):223-237. Epub 2021 Jan 18 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.